Unknown

Dataset Information

0

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants.

ABSTRACT:

SUBMITTER: Xu H 

PROVIDER: S-EPMC8413711 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD.
| S-EPMC8498651 | biostudies-literature
Unknown Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies.
| S-EPMC8420279 | biostudies-literature
Unknown Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity.
| S-EPMC8309970 | biostudies-literature
Unknown hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants.
| S-EPMC8290864 | biostudies-literature
Unknown Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice.
| S-EPMC8724645 | biostudies-literature
Unknown SARS-CoV-2 spike protein (1-up RBD) on EG-grid
| EMPIAR-10951 | biostudies-other
Unknown SARS-CoV-2 spike protein (1-up RBD) on Quantifoil grid
| EMPIAR-10952 | biostudies-other
Unknown Antibodies and Vaccines Target RBD of SARS-CoV-2.
| S-EPMC8100443 | biostudies-literature
Unknown RBD<sub>206</sub>-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern.
| S-EPMC8578908 | biostudies-literature
Unknown Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.
| S-EPMC7802522 | biostudies-literature